Cargando…

Perspective Insight into Future Potential Fusion Gene Transcript Biomarker Candidates in Breast Cancer

Next generation sequencing has accelerated the discovery of a variety of new fusion gene types in clinical breast cancer samples by analyzing cancer genomes and transcriptomes. Although previous studies have focused on a few clinically validated oncogenic fusion genes as diagnostic and therapeutic t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ryong Nam, Moon, Hyeong-Gon, Han, Wonshik, Noh, Dong-Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855724/ https://www.ncbi.nlm.nih.gov/pubmed/29414922 http://dx.doi.org/10.3390/ijms19020502

Ejemplares similares

Reduced proliferation in breast cancer cells contacting the neighboring adipocytes in human breast cancer tissues
por: Ryu, Han Suk, et al.
Publicado: (2015)

Patients with Concordant Triple-Negative Phenotype between Primary Breast Cancers and Corresponding Metastases Have Poor Prognosis
por: Shin, Hee-Chul, et al.
Publicado: (2016)

NAD(P)-dependent steroid dehydrogenase-like is involved in breast cancer cell growth and metastasis
por: Yoon, So-Hyun, et al.
Publicado: (2020)

Endocrine Treatment-Related Symptoms and Patient Outcomes in Breast Cancer: A Meta-Analysis
por: Yoo, Tae-Kyung, et al.
Publicado: (2018)

Reliability of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Han, Ahram, et al.
Publicado: (2013)

An objective nodal staging system for breast cancer patients undergoing neoadjuvant systemic treatment
por: Yoo, Tae-Kyung, et al.
Publicado: (2017)

A Validation Study of a Multiple Reaction Monitoring-Based Proteomic Assay to Diagnose Breast Cancer
por: Kim, Yumi, et al.
Publicado: (2019)

Erratum: A Validation Study of a Multiple Reaction Monitoring-Based Proteomic Assay to Diagnose Breast Cancer
por: Kim, Yumi, et al.
Publicado: (2020)

Enhanced anti-tumor activity and cytotoxic effect on cancer stem cell population of metformin-butyrate compared with metformin HCl in breast cancer
por: Lee, Kyung-Min, et al.
Publicado: (2016)

Correction: Enhanced anti-tumor activity and cytotoxic effect on cancer stem cell population of metformin-butyrate compared with metformin HCl in breast cancer
por: Lee, Kyung-Min, et al.
Publicado: (2021)

Integrative analysis of mutational and transcriptional profiles reveals driver mutations of metastatic breast cancers
por: Lee, Ji-Hyun, et al.
Publicado: (2016)

Detection of Germline Mutations in Breast Cancer Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test
por: Shin, Hee-Chul, et al.
Publicado: (2020)

The Emotional Status, Attitudes in Decision-Making Process, and Their Impact on Surgical Choices in Korean Breast Cancer Patients
por: Jeon, Sook Young, et al.
Publicado: (2021)

Prognostic Influence of BCL2 on Molecular Subtypes of Breast Cancer
por: Hwang, Ki-Tae, et al.
Publicado: (2017)

Survival Improvement in Korean Breast Cancer Patients Due to Increases in Early-Stage Cancers and Hormone Receptor Positive/HER2 Negative Subtypes: A Nationwide Registry-Based Study
por: You, Jee Man, et al.
Publicado: (2015)

Delay of Treatment Initiation Does Not Adversely Affect Survival Outcome in Breast Cancer
por: Yoo, Tae-Kyung, et al.
Publicado: (2016)

Prognostic effect of preoperative serum estradiol level in postmenopausal breast cancer
por: Kim, Ju-Yeon, et al.
Publicado: (2013)

The Clinical Significance and Molecular Features of the Spatial Tumor Shapes in Breast Cancers
por: Moon, Hyeong-Gon, et al.
Publicado: (2015)

Life-Threatening Hematoma in an Elderly Breast Cancer Patient Undergoing Chemotherapy
por: Shin, Ik Beom, et al.
Publicado: (2023)

Adenoid Cystic Carcinoma of the Breast: A Case Series of Six Patients and Literature Review
por: Kim, Miso, et al.
Publicado: (2014)

Effect of standard low-dose anthracycline chemotherapy on late congestive heart failure in breast cancer survivors aged between 50 and 59 at diagnosis: A nationwide study
por: Chung, Il Yong, et al.
Publicado: (2020)

The Effect of Reproductive Factors on Breast Cancer Presentation in Women Who Are BRCA Mutation Carrier
por: Kim, Ju-Yeon, et al.
Publicado: (2017)

Transition into inflammatory cancer-associated adipocytes in breast cancer microenvironment requires microRNA regulatory mechanism
por: Lee, Jiwoo, et al.
Publicado: (2017)

The treatment outcomes and the use of adjuvant therapies in breast cancer patients with severe co-morbidities
por: Han, Jaihong, et al.
Publicado: (2017)

Prediction of axillary lymph node metastasis in primary breast cancer patients using a decision tree-based model
por: Takada, Masahiro, et al.
Publicado: (2012)

Oncologic outcomes after immediate breast reconstruction following mastectomy: comparison of implant and flap using propensity score matching
por: Ha, Jeong Hyun, et al.
Publicado: (2020)

Risk Factors Associated with Distant Metastasis and Survival Outcomes in Breast Cancer Patients with Locoregional Recurrence
por: Park, Soojin, et al.
Publicado: (2015)

Low Rates of Additional Cancer Detection by Magnetic Resonance Imaging in Newly Diagnosed Breast Cancer Patients Who Undergo Preoperative Mammography and Ultrasonography
por: Kim, Jisun, et al.
Publicado: (2014)

Association between Number of Retrieved Sentinel Lymph Nodes and Breast Cancer-related Lymphedema
por: Kim, Hong-Kyu, et al.
Publicado: (2021)

Ki-67 Expression is a Significant Prognostic Factor Only When Progesterone Receptor Expression is Low in Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer
por: Kang, Young-Joon, et al.
Publicado: (2019)

Effects of tamoxifen and aromatase inhibitors on the risk of acute coronary syndrome in elderly breast cancer patients: An analysis of nationwide data
por: Choi, Sung Hyouk, et al.
Publicado: (2020)

Adherence to Guidelines for Cancer Survivors and Health-Related Quality of Life among Korean Breast Cancer Survivors
por: Song, Sihan, et al.
Publicado: (2015)

Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer
por: Moon, Hyeong-Gon, et al.
Publicado: (2012)

In Vivo Tumor Growth Rate Measured by US in Preoperative Period and Long Term Disease Outcome in Breast Cancer Patients
por: Yoo, Tae-Kyung, et al.
Publicado: (2015)

Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer
por: Kim, Jisun, et al.
Publicado: (2012)

Correction: Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer
por: Kim, Jisun, et al.
Publicado: (2012)

Association of Insulin, Metformin, and Statin with Mortality in Breast Cancer Patients
por: Choi, Mihong, et al.
Publicado: (2021)

Protein Phosphatase 1H, Cyclin-Dependent Kinase Inhibitor p27, and Cyclin-Dependent Kinase 2 in Paclitaxel Resistance for Triple Negative Breast Cancers
por: Hur, Saem, et al.
Publicado: (2020)

Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses
por: Yang, Yaewon, et al.
Publicado: (2016)

Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer
por: Lee, Eun-Shin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_i4ngfnlh1lmv9k36ii59j7osmm